U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday. Following the market opening Thursday, the Dow traded up 0.72% to 37,348.90 while the NASDAQ rose 0.96% to 14,919.80. The S&P 500 also rose, gaining, 0.78% to 4,734.96.
DMK Pharmaceuticals Corporation (NASDAQ: DMK) shares are trading higher Thursday after the company announced that it has regained the full rights to commercialize Zimhi (naloxone) after the termination of an exclusive commercialization and
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.58% to 37,296.40 while the NASDAQ rose 0.77% to 14,891.87. The S&P 500 also rose, gaining, 0.68% to 4,730.26.
SAN DIEGO, Dec. 21, 2023 DMK Pharmaceuticals Corporation , a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid.
On Thursday, DMK Pharmaceuticals Corporation (DMK) experienced a significant increase in share price, with a 17% rise, following an announcement that the company has regained full rights to commercialize ZIMHI (naloxone).